:: OIPA Home :: UCLA Home :: Collaboration Newsletter ::  
Contact
 

http://www.research.ucla.edu/tech/diagnostics.htm
  • 2008-449 Novel Diagnostic Assay to Detect Active Tuberculosis
  • 2008-248 Detection of Cancer Stem Cells In Vitro and In Vivo
  • 2007-217 Novel Tumor Associated Antigen Variant for Renal Cell Carinoma Diagnosis and Therapy
  • 2007-216 Vectors for Antibody Expression
  • 2006-707 Identification of Cancer Cells using Atomic Force Microscopy (AFM)
  • 2006-457 Assessing Myelin In Vivo with Specificity
  • 2006-438 SNP Biomarkers for Determining Major Depressive Disorders and Prediction of Patient Response to Anti-depressant Therapy
  • 2006-358 Integrated PCR and Electrochemical Biosensor to Detect Biological Samples
  • 2006-263 Predictive Markers for Dasatinib to Treat Solid Tumors
  • 2005-604 Soluble and Cell-Associated Hemojuvelins as a Therapy and Diagnostic for Iron Metabolism Diseases
  • 2005-500 Haplotypes of WIT3.0 for Screening and Diagnosing Gum Disease
  • 2005-017 Novel Prognostic Factor and Therapeutic Target in Human Renal Cell Carcinoma


  • 2004-675 An Intelligent Nanomedicine Integrating Diagnosis and Therapy
  • 2004-658 Non-Invasive Optometric Device for Detecting Diabetes
  • 2004-657 Non-Invasive Optometric Medical Diagnostic Device
  • 2004-420 Genetic Association of Familial Combined Hyperlipidemia for Diagnostic and Pharmacogenomic Uses
  • 2004-275 A MXXXL Motif Confering Endocytosis of Biomolecules
  • 2004-194 YY1: Novel Prognostic Factor in Human Prostate Cancer
  • 2004-192 New SGLT PET Tracers to Monitor Glucose Transport and Metabolism
  • 2004-099 Artificial Human Mutation Controls for Clinical Diagnostic Genetic and Proficiency Testing
  • 2004-096 Identification of the First Human Glucose Sensor—A New Target for Treatment of Diabetes, Obesity, and Related Metabolic Disorders

  • 2003-075 Shape Encoded Particles (SEPS) for use in Solution Arrays and Decoding Software
  • 2002-463 Method for Using Carbonic Anhydrase IX as a Molecular Marker for Predicting Survival in Advanced Renal Clear Cell Carcinoma
  • 2002-207 NA,K-ATPASE α AND β -Subunits as Tumor Markers for Diagnosis and Prognosis of Bladder Cancer




  • 2000-459 Gastrointestinal Chemosensory Receptors and In Vitro Screening System for Screening of Associated Ligands
  • 2000-236 Granulin as a Target for Tumor Diagnosis and Growth Regulation
  • 2000-044 Universal Vectors for Drug Delivery


  • 1996-615 Mutations in Ataxia-Telangiectasia Gene
  • 1995-543 RNA Binding Fluorochrome: Fluoro Nissl Green
  • 1994-534 Selective Localization of Ultrasound Contrast Agent
  • 1994-516 Diagnostic Test for Proliferative Senescence in Immune Cells
  • 1994-507 A Sensitive Biomarker of Low-Level Lead Exposure
  • 1992-541 Blood Test that Predicts Good Prognosis in AIDS
  • 1992-501 Specific Measure of Tissue Iron at the Resolution of Magnetic Resonanceimaging (MRI)

  • 1990-555 Production of Glutamic Acid Decarboxylase and Associated Polypeptides for use in Clinical and Research Applications


    		• UCLA
    Technologies
    Available for Licensing

    please select from below:
    All Life Sci Tech
    All Phy Sci Tech

    :: OIP Home Page

    The Office of Intellectual Property (OIP) manages a campus-wide patent and invention portfolio resulting from UCLA research funded by more than $750 million per year in federal, state and private contracts and grants.

     Contact information:

     Office of Intellectual Property
    11000 Kinross Ave., Suite 200
    Los Angeles, CA 90095-7231
    Tel. 310.794.0558

    http://www.research.ucla.edu/oip



    :: UCLA Lab Directory


    :: UCLA Research Interests
    :: Collaboration Newsletter


    :: Campus Directory
    :: UCLA main research page
    :: UCLA Home Page
    :: About UCLA


    Copyright © 2003 The Regents of the University of California